Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Dow
Chinese Patent Office
Fuji
Healthtrust
Colorcon
Merck
QuintilesIMS
US Department of Justice

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 010962

« Back to Dashboard

NDA 010962 describes PARACORT, which is a drug marketed by Parke Davis and is included in one NDA. Additional details are available on the PARACORT profile page.

The generic ingredient in PARACORT is prednisone. There are sixteen drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the prednisone profile page.
Summary for 010962
Tradename:PARACORT
Applicant:Parke Davis
Ingredient:prednisone
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Inflammatory Bowel Disease Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 010962

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength5MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Federal Trade Commission
Cipla
Fish and Richardson
Baxter
Julphar
Medtronic
Covington
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.